Pharmacil is a key pharmaceutical company under the Radiant Group in Bangladesh. Established in 2005 and headquartered in Dhaka, Bangladesh, it boasts modern pharmaceutical production facilities. Since its inception, the company has been committed to the research, development, and production of high-quality drugs, serving as a core force for the group in driving innovative drug development and international expansion. With advanced production equipment, a stringent quality management system, and continuous investment in research and development, Pharmacil Limited has gradually built a strong brand influence in the pharmaceutical industries of South and Southeast Asia.
Manufacturing Facilities & Compliance
Pharmacil’s manufacturing facilities strictly comply with cGMP (current Good Manufacturing Practice) requirements, are registered and supervised by the Ministry of Health of Bangladesh, and have obtained multiple international certifications.
The factory is equipped with advanced automated production lines and cleanrooms, covering solid, liquid, and sterile dosage forms.
To ensure product quality, the company implements full-process quality control, with strict monitoring and testing mechanisms from raw material procurement to manufacturing processes and finished product inspection, ensuring that every batch meets international pharmaceutical standards.
Technology Platform & R&D Capabilities
Pharmacil has a professional R&D team and modern laboratories, capable of developing new drugs, improving generic drugs, and researching complex formulations. The company focuses on oncology, antiviral, immunomodulatory, and chronic disease treatments, actively adopting cutting-edge international pharmaceutical technologies to enhance efficacy and accessibility.
Pharmacil maintains long-term partnerships with several globally renowned pharmaceutical companies, including Roche, Pfizer, Bayer, Cipla, and Glenmark. In 2024, the company entered into a strategic partnership with Novartis, marking a significant milestone. Both parties collaborate closely in oncology drug applications, joint research and development, and regional market expansion.
Through its deep cooperation with Novartis, Pharmacil has successfully introduced multiple innovative medicines to Bangladesh and ASEAN markets, while also gaining extensive experience in regulatory approvals, clinical trials, and market promotion. This collaboration enhances access to effective and reliable therapies for patients across the region.
Production Capacity & Quality Assurance
Pharmacil’s manufacturing system has an annual production capacity of hundreds of millions of doses, supplying not only the local Bangladeshi market but also ASEAN and other international markets.
The company has established comprehensive warehousing and supply chain management systems, strictly implementing pharmaceutical storage and transportation standards to ensure safety and traceability from production to delivery.
Throughout production and supply, the company upholds a “quality first” principle and has established internal quality standards in compliance with WHO, US FDA, and EMA requirements, laying a solid foundation for international drug registration and market access.
Mission & Future Outlook
Pharmacil’s mission is to drive high-quality pharmaceutical production through technological innovation for the benefit of patients worldwide, continually increasing R&D investment, optimizing production systems, and achieving international certification to meet growing global clinical demand.
In the future, the company plans to expand factory capacity further, introduce more production lines meeting international standards, and actively explore deeper cooperation with global pharmaceutical enterprises. Supported by the Radiant Group and its international strategy, Pharmacil is gradually becoming a modern pharmaceutical company integrating R&D, manufacturing, and international supply in South and Southeast Asia.
Currently, the company is advancing the registration of multiple core products in several ASEAN countries and is rigorously complying with local regulations for controlled substances to ensure operational compliance and sustainable growth.
Source:：https://www.radiantpharmacil.com/about.html
暂无评论内容